WhiteLab Genomics specializes in using artificial intelligence to optimize drug design and accelerate genomic medicine. Their platform focuses on improving the safety and efficacy of genomic therapies.
About WhiteLab Genomics
WhiteLab Genomics leverages AI to enhance the development of genomic medicine by optimizing biological data-guided rational design. The company collaborates with partners to create novel viral vectors and develop personalized drugs, addressing major health challenges through AI-powered solutions.
Model Training PlatformsAI Design ToolsPredictive Analytics
Media
No media yet
Screenshots and product tours appear here once the vendor claims this page.
Features
Optimize therapeutic candidates for safety and efficacy
Integrate biomarker mapping, receptor-ligand prediction, and transcriptomic analysis
Identify and design therapeutic targets using predictive modeling
Curate and enrich public and proprietary datasets for genomic medicine
Predict cell surface protein locations using deep learning
Design AAV capsids with enhanced safety and efficacy using protein language models
Map biomarkers with a comprehensive atlas including 1,000+ datasets
Assess and optimize ligand binding to therapeutic targets